Clinical trial
Topotecan in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube…
NCT00055614 · Beth Israel Deaconess Medical Center, Other · Completed
Key facts
| NCT number | NCT00055614 |
|---|---|
| Title | Topotecan in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer |
| Official title | Phase I Study of Oral Topotecan as Consolidation for Patients With Mullerian Origin Tumors (Ovary, Tube, Peritoneum) |
| Lead sponsor | Beth Israel Deaconess Medical Center, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer |
| Intervention type | Drug, Procedure |
| Interventions | topotecan hydrochloride, adjuvant therapy |
| Enrollment | 20 |
| Start date | May 1, 2002 |
| Completion | Oct 1, 2007 |
| First posted | Mar 7, 2003 |
| Last update posted | Jun 26, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: